ANEB
NASDAQ · Pharmaceuticals
Anebulo Pharmaceuticals Inc
$0.26
+0.00 (+0.00%)
Open$0.26
Previous Close$0.26
Day High$0.26
Day Low$0.00
52W High$2.65
52W Low—
Volume—
Avg Volume1.9K
Market Cap11.22M
P/E Ratio—
EPS$-0.19
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+19,126.9% upside
Current
$0.26
$0.26
Target
$49.99
$49.99
$34.23
$49.99 avg
$60.95
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 5.41M | 5.09M | 4.82M |
| Net Income | 1.02M | 757.9K | 675.0K |
| Profit Margin | 18.8% | 14.9% | 14.0% |
| EBITDA | 1.84M | 1.51M | 1.49M |
| Free Cash Flow | 747.3K | 835.9K | 744.4K |
| Rev Growth | +9.4% | +17.9% | +10.5% |
| Debt/Equity | 0.83 | 0.81 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,354.00 | -0.79% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $276.22 | +1.43% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.73 | -0.14% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.39 | -1.64% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $79.40 | -3.30% | 12.8 | 33.59B |